Ahsan Farooqi

Ahsan Farooqi is an Assistant Professor and Associate Patient Safety Quality Officer at The University of Texas MD Anderson Cancer Center. His research focuses on clinical radiation oncology, particularly the treatment of soft tissue sarcoma, melanoma, and other rare malignancies through combined modality approaches. He investigates the integration of neoadjuvant radiation therapy with immune checkpoint blockade, as evidenced by recent work on undifferentiated pleomorphic sarcoma and dedifferentiated liposarcomas. His latest publications also address setup uncertainty quantification between CT and MR guidance in intramuscular metastases radiotherapy, surgical reconstruction toxicity following hypofractionated adjuvant radiation, and outcomes for metastatic soft tissue sarcoma. His work spans surgical oncology, pathology, and cancer treatment optimization.